Insurers heavily subsidize the cost of ivermectin prescriptions for COVID, despite the lack of evidence that ivermectin is effective for COVID. In a new paper, published in JAMA, Questrom professor and TPRI co-lead Rena Conti with colleagues Kao-Ping Chua and Nora Becker (both University of Michigan) estimate that U.S. insurers may have wasted $2.5 million on these drugs in the week of August 13, 2021 alone.
TPRI faculty co-lead and Questrom faculty Rena Conti will testify at the upcoming U.S. House of Representatives hearing of the Committee on Oversight and Reform, entitled “Unsustainable Drug Prices: Findings from the Committee’s Drug Pricing Investigation and the Need for Structural Reforms.” on Friday, December 10, 2021, at 10 a.m. Professor Conti will discuss recently published papers germane to the current public debate on lowering prescription drug prices.
James Bessen’s research mentioned in The Economist, December 4, 2021.
James Bessen quoted in The Washington Post, November 26, 2021.
James Bessen’s research cited in The Quartz Weekend Brief Email, November 13, 2021.
James Bessen quoted in The Washington Post, October 15, 2021.
James Bessen, Erich Denk, Joowon Kim, Cesare Righi
This paper reports the first recent estimates of trends in the displacement of industry-leading firms. Displacement hazards rose for several decades since 1970 but have declined sharply since 2000. Using a production function-based model to explore the role of investments, acquisitions, and lobbying, we find that investments by dominant firms in intangibles, especially software, are distinctly associated with greater persistence and reduced leapfrogging.
James Bessen quoted in Full Stack Economics on the adoption of new technology and its impact on workers.
James Bessen, Stephen Michael Impink, Lydia Reichensperger, and Robert Seamans
Results from TPRI’s 2021 AI Ethics survey shed light on how startups approach the uncertain landscape of ethics and Artificial Intelligence.